China’s CAR T-Cell Therapy Industry Booms With Shanghai At Center

 
• By Mainbayar Badarch

According to China Pharmaceutical Innovation and Research Development Association, in the first quarter of 2024 a total of 44 cell therapies in the domestic cell therapy field made clinical application progress, including 28 immune cell therapies and 16 stem cell therapies.  

3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration

More from Global Vision

More from In Vivo